Biorepository for Discovery and Validation of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema


Lead sponsor: Mayo Clinic

Source Mayo Clinic
Brief Summary

Researchers are collecting information, saliva, blood and tissue from subjects with lymphedema to store for future research.

Overall Status Recruiting
Start Date August 1, 2019
Completion Date August 2023
Primary Completion Date August 2022
Study Type Observational [Patient Registry]
Primary Outcome
Measure Time Frame
Biospecimen Acquisition 1 year
Enrollment 100

Sampling method: Non-Probability Sample


Inclusion Criteria:

- Adult (18+ years of age)

- Ability to provide written consent

- Has been diagnosed with Lymphedema

Exclusion Criteria:

- Under the age of 18 years old

- Inability to provide written consent

- Previous lymphovenous bypass or lymph node transfer surgery

- Major changes occur to co-morbid conditions

- Proven ICG or iodine allergy

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Overall Official
Last Name Role Affiliation
Antonio Forte, MD, PhD Principal Investigator Mayo Clinic
Overall Contact

Last name: Antonio Forte, MD, PhD

Phone: 904-953-2073

Email: [email protected]

facility status contact Mayo Clinic in Florida Antonio Forte, MD, PhD
Location Countries

United States

Verification Date

October 2019

Responsible Party

Responsible party type: Principal Investigator

Investigator affiliation: Mayo Clinic

Investigator full name: Antonio J. Forte

Investigator title: Principal Investigator

Has Expanded Access No
Condition Browse
Patient Data No
Study Design Info

Observational model: Case-Only

Time perspective: Prospective